| Dietary phospholipids and intestinal cholesterol absorption JS Cohn, A Kamili, E Wat, RWS Chung, S Tandy Nutrients 2 (2), 116-127, 2010 | 267 | 2010 |
| Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-β peptide generation WS Kim, AS Rahmanto, A Kamili, KA Rye, GJ Guillemin, IC Gelissen, ... Journal of Biological Chemistry 282 (5), 2851-2861, 2007 | 233 | 2007 |
| Dietary krill oil supplementation reduces hepatic steatosis, glycemia, and hypercholesterolemia in high-fat-fed mice S Tandy, RWS Chung, E Wat, A Kamili, K Berge, M Griinari, JS Cohn Journal of agricultural and food chemistry 57 (19), 9339-9345, 2009 | 196 | 2009 |
| Dietary phospholipids, hepatic lipid metabolism and cardiovascular disease JS Cohn, E Wat, A Kamili, S Tandy Current opinion in lipidology 19 (3), 257-262, 2008 | 180 | 2008 |
| Dietary phospholipid-rich dairy milk extract reduces hepatomegaly, hepatic steatosis and hyperlipidemia in mice fed a high-fat diet E Wat, S Tandy, E Kapera, A Kamili, RWS Chung, A Brown, M Rowney, ... Atherosclerosis 205 (1), 144-150, 2009 | 146 | 2009 |
| Reduction in intestinal cholesterol absorption by various food components: mechanisms and implications JS Cohn, A Kamili, E Wat, RWS Chung, S Tandy Atherosclerosis Supplements 11 (1), 45-48, 2010 | 118 | 2010 |
| Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma LD Gamble, S Purgato, J Murray, L Xiao, DMT Yu, KM Hanssen, ... Science Translational Medicine 11 (477), eaau1099, 2019 | 117 | 2019 |
| Dietary sphingomyelin lowers hepatic lipid levels and inhibits intestinal cholesterol absorption in high-fat-fed mice RWS Chung, A Kamili, S Tandy, JM Weir, R Gaire, G Wong, PJ Meikle, ... PLoS One 8 (2), e55949, 2013 | 64 | 2013 |
| Hepatic accumulation of intestinal cholesterol is decreased and fecal cholesterol excretion is increased in mice fed a high-fat diet supplemented with milk phospholipids A Kamili, E Wat, RWS Chung, S Tandy, JM Weir, PJ Meikle, JS Cohn Nutrition & metabolism 7, 1-12, 2010 | 61 | 2010 |
| Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation M Le Grand, A Mukha, J Püschel, E Valli, A Kamili, O Vittorio, ... Theranostics 10 (14), 6411, 2020 | 44 | 2020 |
| Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy A Kamili, AJ Gifford, N Li, C Mayoh, SO Chow, TW Failes, GL Eden, ... British journal of cancer 122 (5), 680-691, 2020 | 43 | 2020 |
| TPD52 expression increases neutral lipid storage within cultured cells A Kamili, N Roslan, S Frost, LC Cantrill, D Wang, A Della-Franca, ... Journal of cell science 128 (17), 3223-3238, 2015 | 40 | 2015 |
| Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects against MYCN‐amplified neuroblastoma AE Tee, OC Ciampa, M Wong, JI Fletcher, A Kamili, J Chen, N Ho, Y Sun, ... International journal of cancer 147 (7), 1928-1938, 2020 | 35 | 2020 |
| Hydrogenated phosphatidylcholine supplementation reduces hepatic lipid levels in mice fed a high-fat diet S Tandy, RWS Chung, A Kamili, E Wat, JM Weir, PJ Meikle, JS Cohn Atherosclerosis 213 (1), 142-147, 2010 | 33 | 2010 |
| Tumor protein D52 represents a negative regulator of ATM protein levels Y Chen, A Kamili, J Hardy, G Groblewski, KK Khanna, J Byrne Cell Cycle 12 (18), 3083-3097, 2013 | 32 | 2013 |
| Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy J Chen, C Nelson, M Wong, AE Tee, PY Liu, T La, JI Fletcher, A Kamili, ... Clinical Cancer Research 27 (5), 1438-1451, 2021 | 26 | 2021 |
| Mouse models of high-risk neuroblastoma A Kamili, C Atkinson, TN Trahair, JI Fletcher Cancer and Metastasis Reviews 39 (1), 261-274, 2020 | 24 | 2020 |
| Dual targeting of chromatin stability by the curaxin CBL0137 and histone deacetylase inhibitor panobinostat shows significant preclinical efficacy in neuroblastoma L Xiao, K Somers, J Murray, R Pandher, M Karsa, E Ronca, A Bongers, ... Clinical Cancer Research 27 (15), 4338-4352, 2021 | 22 | 2021 |
| In vitro and in vivo drug screens of tumor cells identify novel therapies for high‐risk child cancer LMS Lau, C Mayoh, J Xie, P Barahona, KL MacKenzie, M Wong, A Kamili, ... EMBO molecular medicine 14 (4), e14608, 2022 | 21 | 2022 |
| Suppression of ABCE1-mediated mRNA translation limits N-MYC–driven cancer progression J Gao, MS Jung, C Mayoh, P Venkat, KM Hannan, JI Fletcher, A Kamili, ... Cancer research 80 (17), 3706-3718, 2020 | 17 | 2020 |
